» Articles » PMID: 16084159

Depressive Symptoms and Inflammation Among Heart Failure Patients

Overview
Journal Am Heart J
Date 2005 Aug 9
PMID 16084159
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psychological depression has been linked to heart failure, both an antecedent to and as a risk factor for poor outcomes among patients with existing heart failure. Elevated levels of proinflammatory cytokines have been proposed as a possible physiological link between the 2 conditions. The objective of this study was to examine the proinflammatory cytokines interleukin (IL)-6, IL-1beta, and tumor necrosis factor-alpha (TNFalpha) in heart failure patients with and without elevated symptoms of depression.

Methods: Thirty-two heart failure patients were recruited from an outpatient heart failure clinic. Depressive symptoms were measured with the Beck Depression Inventory (BDI), and a patient was classified as having elevated symptoms of depression if he/she scored > or = 10. The cognitive-affective subscale score of the BDI, which measures depressed mood independent of physical symptoms, was also examined.

Results: In the multiple linear regression models controlling for age, sex, smoking, and antidepressant medication use, there was no relation between BDI score and IL-6 (P = .7612) or IL-1beta (P = .8261). However, there was a statistically significant positive relation between BDI score and TNFalpha (P = .0374). There was also a significant relation between an elevated cognitive-affective score and TNFalpha (P = .0322) but no association with IL-6 (P = .8593) or IL-1beta (P = .3737).

Conclusions: The association between TNFalpha and the cognitive-affective subscale, which eliminates the physical signs and symptoms that are shared by depression and heart failure, demonstrates a depression-specific activation of proinflammatory cytokines that may promote disease progression and mortality in patients with heart failure.

Citing Articles

Heart failure symptom burden, dietary intake, and inflammation: An integrative review of the literature.

Davis E, Dunbar S, Higgins M, Wood K, Ferranti E, Morris A J Integr Nurs. 2023; 5(2):81-92.

PMID: 37727310 PMC: 10508190. DOI: 10.4103/jin.jin_26_23.


The Heart Is at Risk: Understanding Stroke-Heart-Brain Interactions with Focus on Neurogenic Stress Cardiomyopathy-A Review.

Ziaka M, Exadaktylos A J Stroke. 2023; 25(1):39-54.

PMID: 36592971 PMC: 9911836. DOI: 10.5853/jos.2022.02173.


The Emerging Role of Combined Brain/Heart Magnetic Resonance Imaging for the Evaluation of Brain/Heart Interaction in Heart Failure.

Markousis-Mavrogenis G, Noutsias M, Rigopoulos A, Giannakopoulou A, Gatzonis S, Pons R J Clin Med. 2022; 11(14).

PMID: 35887772 PMC: 9322381. DOI: 10.3390/jcm11144009.


Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients.

Altamura M, DAndrea G, Angelini E, Tortorelli F, Balzotti A, Porcelli P PLoS One. 2022; 17(3):e0265282.

PMID: 35271674 PMC: 8912235. DOI: 10.1371/journal.pone.0265282.


Severity, Progress, and Related Factors of Mood Disorders in Patients with Coronary Artery Disease: A Retrospective Study.

Lee C, Lee S, Shin Y, Park S, Won K, Ann S Healthcare (Basel). 2020; 8(4).

PMID: 33339355 PMC: 7766069. DOI: 10.3390/healthcare8040568.